ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000261533.1	Motesanib	Breast invasive carcinoma	0.029853011	Resistant
ENSG00000261533.1	Motesanib	Stomach adenocarcinoma	0.024145086	Sensitive